Stanley Druckenmiller acquired 14.9 Million Teva- Pharmaceutical Industries Ltd. shares worth $253 Million. That's 7.83% of their entire equity portfolio (2nd largest holding). The investor owns 1.30% of the outstanding Teva- Pharmaceutical Industries Ltd. stock. The first Teva- Pharmaceutical Industries Ltd. trade was made in Q4 2013. Since then Stanley Druckenmiller bought shares four more times and sold shares on two occasions. The investor's estimated purchase price is $269 Million, resulting in a loss of 5.9%.